Antihypertensive Effects of SGLT2-Inhibitors: Considerations for Clinical Practice

被引：0
作者：
Da Porto, Andrea [1 ]
Bulfone, Luca [2 ]
Sechi, Leonardo [1 ,2 ]
机构：
[1] Univ Udine, Diabet & Metab Unit, Clin Med, Udine, Italy
[2] Univ Udine, ESH Excellence Hypertens Ctr, Clin Med, Udine, Italy
来源：
CURRENT VASCULAR PHARMACOLOGY | 2024年 / 22卷 / 04期
关键词：
BLOOD-PRESSURE; DAPAGLIFLOZIN;
D O I：
10.2174/0115701611274645231208102130
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：231 / 233
页数：3
相关论文
共 21 条
  • [1] Insulin Resistance and High Blood Pressure: Mechanistic Insight on the Role of the Kidney
    Brosolo, Gabriele
    Da Porto, Andrea
    Bulfone, Luca
    Vacca, Antonio
    Bertin, Nicole
    Scandolin, Laura
    Catena, Cristiana
    Sechi, Leonardo A.
    [J]. BIOMEDICINES, 2022, 10 (10)
  • [2] Plasma Lipoprotein(a) Levels as Determinants of Arterial Stiffening in Hypertension
    Brosolo, Gabriele
    Da Porto, Andrea
    Bulfone, Luca
    Vacca, Antonio
    Bertin, Nicole
    Colussi, Gianluca
    Cavarape, Alessandro
    Sechi, Leonardo A.
    Catena, Cristiana
    [J]. BIOMEDICINES, 2021, 9 (11)
  • [3] SGLT2 inhibition ameliorates nano plastics-induced premature endothelial senescence and dysfunction
    Dhakal, Bikalpa
    Shiwakoti, Saugat
    Park, Eun-Young
    Kang, Ki-Woon
    Schini-Kerth, Valerie B.
    Park, Sun-Hwa
    Ji, Hye-Young
    Park, Joon Seok
    Ko, Ju-Young
    Oak, Min-Ho
    [J]. SCIENTIFIC REPORTS, 2023, 13 (01)
  • [4] Canagliflozin, Blood Pressure Variability, and Risk of Cardiovascular, Kidney, and Mortality Outcomes: Pooled Individual Participant Data From the CANVAS and CREDENCE Trials
    Fletcher, Robert A.
    Arnott, Clare
    Rockenschaub, Patrick
    Schutte, Aletta E.
    Carpenter, Lewis
    Vaduganathan, Muthiah
    Agarwal, Rajiv
    Bakris, George
    Chang, Tara I.
    Heerspink, Hiddo J. L.
    Jardine, Meg J.
    Mahaffey, Kenneth W.
    Neal, Bruce
    Pollock, Carol
    Jun, Min
    Rodgers, Anthony
    Perkovic, Vlado
    Neuen, Brendon L.
    [J]. JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2023, 12 (13):
  • [5] Empagliflozin in Patients with Chronic Kidney Disease
    Herrington, William G.
    Staplin, Natalie
    Wanner, Christoph
    Green, Jennifer B.
    Hauske, Sibylle J.
    Emberson, Jonathan R.
    Preiss, David
    Judge, Parminder
    Mayne, Kaitlin J.
    Ng, Sarah Y. A.
    Sammons, Emily
    Zhu, Doreen
    Hill, Michael
    Stevens, Will
    Wallendszus, Karl
    Brenner, Susanne
    Cheung, Alfred K.
    Liu, Zhi-Hong
    Li, Jing
    Hooi, Lai Seong
    Liu, Wen
    Kadowaki, Takashi
    Nangaku, Masaomi
    Levin, Adeera
    Cherney, David
    Maggioni, Aldo P.
    Pontremoli, Roberto
    Deo, Rajat
    Goto, Shinya
    Rossello, Xavier
    Tuttle, Katherine R.
    Steubl, Dominik
    Petrini, Michaela
    Massey, Dan
    Eilbracht, Jens
    Brueckmann, Martina
    Landray, Martin J.
    Baigent, Colin
    Haynes, Richard
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2023, 388 (02) : 117 - 127
  • [6] Pleiotropic effect of sodium-glucose cotransporter 2 inhibitors on blood pressure
    Kao, Ting-Wei
    Huang, Chin-Chou
    [J]. FRONTIERS IN CARDIOVASCULAR MEDICINE, 2022, 9
  • [7] Twenty-Four-Hour Blood Pressure-Lowering Effect of a Sodium-Glucose Cotransporter 2 Inhibitor in Patients With Diabetes and Uncontrolled Nocturnal Hypertension Results From the Randomized, Placebo-Controlled SACRA Study
    Kario, Kazuomi
    Okada, Kenta
    Kato, Mitsutoshi
    Nishizawa, Masafumi
    Yoshida, Tetsuro
    Asano, Tsuguyoshi
    Uchiyama, Kazuaki
    Niijima, Yawara
    Katsuya, Tomohiro
    Urata, Hidenori
    Osuga, Jun-ichi
    Fujiwara, Takeshi
    Yamazaki, Shoji
    Tomitani, Naoko
    Kanegae, Hiroshi
    [J]. CIRCULATION, 2019, 139 (18) : 2089 - 2097
  • [8] Effect of sodium-glucose cotransporter-2 inhibitors on blood pressure in patients with heart failure: a systematic review and meta-analysis
    Li, Min
    Yi, Tieci
    Fan, Fangfang
    Qiu, Lin
    Wang, Zhi
    Weng, Haoyu
    Ma, Wei
    Zhang, Yan
    Huo, Yong
    [J]. CARDIOVASCULAR DIABETOLOGY, 2022, 21 (01)
  • [9] Empagliflozin Improves the MicroRNA Signature of Endothelial Dysfunction in Patients with Heart Failure with Preserved Ejection Fraction and Diabetes
    Mone, Pasquale
    Lombardi, Angela
    Kansakar, Urna
    Varzideh, Fahimeh
    Jankauskas, Stanislovas S.
    Pansini, Antonella
    Marzocco, Stefania
    De Gennaro, Stefano
    Famiglietti, Michele
    Macina, Gaetano
    Frullone, Salvatore
    Santulli, Gaetano
    [J]. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2023, 384 (01) : 116 - 122
  • [10] SGLT2 Inhibition via Empagliflozin Improves Endothelial Function and Reduces Mitochondrial Oxidative Stress: Insights From Frail Hypertensive and Diabetic Patients
    Mone, Pasquale
    Varzideh, Fahimeh
    Jankauskas, Stanislovas S.
    Pansini, Antonella
    Lombardi, Angela
    Frullone, Salvatore
    Santulli, Gaetano
    [J]. HYPERTENSION, 2022, 79 (08) : 1633 - 1643
123